From the Pritzker Administration:
Governor Pritzker Announces Major AbbVie Manufacturing Expansion
Company’s investment will create 300 new jobs in Chicagoland region
NORTH CHICAGO – Governor JB Pritzker, the Illinois Department of Commerce and Economic Opportunity (DCEO), and the Illinois Economic Development Corporation (Illinois EDC) announced today that AbbVie will construct two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago location, investing $380 million and creating 300 new full-time jobs.
This new investment underscores Illinois’ robust and rapidly expanding life sciences ecosystem, supported by a skilled workforce, robust infrastructure, and a strong manufacturing sector.
“AbbVie’s significant investment fortifies Illinois’ position as a global biomanufacturing leader while creating hundreds of new jobs,” said Governor JB Pritzker. “With our world-class workforce, modern infrastructure, strategic location, and cutting-edge research ecosystem, this expansion underscores why Illinois is the best place to grow and innovate. Together, we’re advancing pharmaceutical manufacturing and R&D and building a stronger economic future for communities across Illinois.”
Guided by Illinois’ Economic Growth Plan, Governor Pritzker continues to build the foundation for long-term success by focusing on key growth industries including life sciences and advanced manufacturing. With AbbVie’s investment, Illinois continues to strengthen its position as a global hub for both life sciences and advanced manufacturing.
